The Effect of Polymer-Drug Ratio on Characteristics, Release and Stability of Ciprofloxacin-Alginate-Kappa Carrageenan Microspheres http://www.doi.org/10.26538/tjnpr/v7i11.38
Main Article Content
Abstract
Tuberculosis is the top contagious disease in the world caused by the bacterium Mycobacterium tuberculosis. The increasing incidence of drug resistance in Mycobacterium tuberculosis requires alternative therapies, one of which is fluoroquinolones such as ciprofloxacin. Pulmonary delivery systems are used to avoid problems with oral administration, such as first-pass metabolism and targeted delivery. Microsphere formulation is chosen because pulmonary delivery requires a small size (1-5µm) for deposition in the lungs. The purpose of this research is to investigate the influence of the drug-polymer ratio on the characteristics, release, and stability of the microspheres. The polymer used is a combination of sodium alginate and kappa carrageenan. Microspheres were prepared using the ionic gelation technique with aerosolization. The results showed spherical microspheres with smooth surfaces, particle sizes were ranging from 2.25 ± 0.14 µm to 2.83 ± 0.12 µm, moisture contents were below 5%, flow properties were good, yields were ranging from 91.71% ± 5.52 to 93.62% ± 3.97, drug loadings were 2.03% ± 0.12 - 3.55% ± 0.13, and entrapment effiencies were ranging from 75.27% ± 2.57 to 78.45% ± 1.89. Over a period of 720 minutes, ciprofloxacin release from the microspheres were about 48.20% - 91.35%. The release of ciprofloxacin increased with higher ratio of drug-polymer, and the release kinetics followed the Korsmeyer-Peppas model with a release mechanism following Fick's diffusion law. Microspheres remained stable over 28 days. The study suggest that this microspheres system holds significant potential as a drug delivery system to the lungs.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
World Heath O. Global tuberculosis report 2022. Work Heal Saf. 2022;68.
Akcali S, Surucuoglu S, Cicek C, Ozbakkaloglu B. In vitro activity of ciprofloxacin, ofloxacin, and levofloxacin against Myobacterium tuberculosis. Ann Saudi Med. 2005;25(5):409–12.
Rodriguez JC, Ruiz P, Causse M, Vaquero M, Casal M. In Vitro Activity of Tedizolid against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2001;63(4):229–31.
Katzung. Basic & Clinical Pharmacology. McGraw-Hill Education. New York. 2018 : 14.
Hariyadi DM, Purwanti T, Adilla S. Influence of crosslinker concentration on the characteristics of erythropoietin-alginate microspheres. 2018;6(200):250–9.
Paranjpe M, Müller-Goymann CC. Nanoparticle-mediated pulmonary drug delivery: A review. Int J Mol Sci. 2014;15(4):5852–73.
El-Sherbiny IM, El-Baz NM, Yacoub MH. Inhaled nano- and microparticles for drug delivery. Glob Cardiol Sci Pract. 2015(1):1–14.
Hariyadi DM, Hendradi E, Pratama HE. A Review microspheres as pulmonary delivery systems. Journal Chinese Pharm Sci 2021:30(7): 545-555
Yue S, Zhang B, Sun R, Liu W, Zhu Q, Zhang X, Wang R, Chen C. PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Taylor & Francis Group 2021. 28: 1397-1418.
Patil JS & Sarasija S. Pulmonary drug delivery strategies: A concise, systematic review. Lung India. 2012;29(1), 44–49.
Rastogi R, Sultana Y, Aqil M, Ali A, Kumar S, Chuttani K, & Mishra AK. Alginate microspheres of isoniazid for oral sustained drug delivery. Int Jour of Pharm, 2017;334, 71–77.
Annisa V, Sulaiman TNS, Nugroho AK, Nugroho AE. Review Sinergisitas Kombinasi Polimer Alami Serta Pemanfaatan dalam Formulasi Obat. Maj Farmasetika. 2021;6(5):436.
Ataide J, Cefali L, Rebelo M, Spir L, Tambourgi E, Jozala A, et al. Bromelain Loading and Release from a Hydrogel Formulated Using Alginate and Arabic Gum. Planta Med. 2017;83(10):870–6.
Dounighi MN, Eskandari R, Avadi MR, Zolfagharian H, Mir Mohammad Sadeghi A, Rezayat M. Preparation and in vitro characterization of chitosan nanoparticles containing Mesobuthus eupeus scorpion venom as an antigen delivery system. J Venom Anim Toxins Incl Trop Dis. 2012;18(1):44–52.
Azhar SN, Ashari SE, Ahmad S, Salim N. In vitro kinetic release study, antimicrobial activity and in vivo toxicity profile of a kojic acid ester-based nanoemulsion for topical application. Roya Society of Chemistry. 2020. 10. 43894.
Hariyadi DM, Hendradi E, Kurniawan TD. Alginate Microspheres Encapsulating Ciprofloxacin HCl: Characteristics, Release, and Antibacterial Activity. Int J of Pharm Research and Health Sci, 2019;7(4), 3020–3027.
Hariyadi DM, Hendradi E, Sharon N. Development of Carrageenan Polymer for Encapsulation of Ciprofloxacin HCL: In Vitro Characterization. Int J Drug Deliv Technol. 2019;9(01):89–93.
Debnath SK, Saisivam S, Debanth M, Omri A. Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of Prothionamide. PLoS One. 2018;13(1):1–12.
Chaurasiya B, Zhao Y-Y. Dry Powder for Pulmonary Delivery: A Comprehensive Review. Pharmaceutics. 2020;13(1):31.
Vishwa B, Moin A, Gowda D V., Rizvi SMD, Hegazy WAH, Abu Lila AS. Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis. Pharmaceutics. 2021;13(1):79.
Kumar BP, Chandiran IS, Bhavya B, Sindhuri M, Pharmaceutics D, Krishna G. Microparticulate Drug Delivery Systems. Handb Encapsulation Control Release. 2015;1(1):1091–134.
Abdullah MF, Nuge T, Andriyana A, Ang BC, Muhamad F. Core-Shell Fibers: Design, Roles, and Controllable Release Strategies in Tissue Engineering and Drug Delivery. MDPI. 2019:1-45.
Bruschi ML. Strategies to Modify the Drug Release from Pharmaceutical Systems. Elsevier; 2015.
Annisa V, Sulaiman TN, Nugroho AK, Nugroho A E. Review of the Synergy of Natural Polymer Combinations and Their Use in Drug Formulation. Farmaceutical 2021:6(5):436.